Brief: Galectin Therapeutics Inc - Reports Significant Reduction In New Varices With Belapectin
18/02/2025 14:49
Feb 18 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS INC - REPORTS SIGNIFICANT REDUCTION
IN NEW
VARICES WITH BELAPECTIN
* GALECTIN THERAPEUTICS INC - NAVIGATE TRIAL SHOWS 68.1%
REDUCTION
IN NEW VARICES WITH BELAPECTIN
* GALECTIN THERAPEUTICS INC - ADDITIONAL DATA OF NAVIGATE
TRIAL
EXPECTED BY END OF Q1 2025
Source text: ID:n0001140361-25-004971
Further company coverage: GALT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study